CD8A and breast carcinoma: Xie F et al. [55] observed that breast cancer cells secrete TEV enriched in active TGF-β type II receptor (TβRII) which transfer to CD8+ T cells induced the activation of transforming growth factor-beta signaling protein 3 (SMAD3).